1. Home
  2. CTMX vs OPAL Comparison

CTMX vs OPAL Comparison

Compare CTMX & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • OPAL
  • Stock Information
  • Founded
  • CTMX 2008
  • OPAL 1998
  • Country
  • CTMX United States
  • OPAL United States
  • Employees
  • CTMX N/A
  • OPAL N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • CTMX Health Care
  • OPAL Utilities
  • Exchange
  • CTMX Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • CTMX 85.3M
  • OPAL 87.0M
  • IPO Year
  • CTMX 2015
  • OPAL N/A
  • Fundamental
  • Price
  • CTMX $0.83
  • OPAL $3.10
  • Analyst Decision
  • CTMX Buy
  • OPAL Buy
  • Analyst Count
  • CTMX 6
  • OPAL 5
  • Target Price
  • CTMX $5.77
  • OPAL $6.78
  • AVG Volume (30 Days)
  • CTMX 785.3K
  • OPAL 122.4K
  • Earning Date
  • CTMX 03-10-2025
  • OPAL 03-12-2025
  • Dividend Yield
  • CTMX N/A
  • OPAL N/A
  • EPS Growth
  • CTMX N/A
  • OPAL N/A
  • EPS
  • CTMX 0.16
  • OPAL 0.18
  • Revenue
  • CTMX $126,617,000.00
  • OPAL $306,957,000.00
  • Revenue This Year
  • CTMX $22.55
  • OPAL $23.40
  • Revenue Next Year
  • CTMX N/A
  • OPAL $29.66
  • P/E Ratio
  • CTMX $4.97
  • OPAL $17.44
  • Revenue Growth
  • CTMX 33.66
  • OPAL 30.17
  • 52 Week Low
  • CTMX $0.75
  • OPAL $2.91
  • 52 Week High
  • CTMX $5.85
  • OPAL $5.18
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 44.23
  • OPAL 47.96
  • Support Level
  • CTMX $0.75
  • OPAL $2.94
  • Resistance Level
  • CTMX $0.98
  • OPAL $3.19
  • Average True Range (ATR)
  • CTMX 0.06
  • OPAL 0.10
  • MACD
  • CTMX 0.00
  • OPAL 0.02
  • Stochastic Oscillator
  • CTMX 33.17
  • OPAL 67.39

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: